On Wednesday, Las Vegas-primarily based testing laboratory, information analytics, and formulation firm, Digipath announced that its subsidiary GroSciences had initiated the beta-testing phase of its Tru-Hemp ID kit in North Carolina and Vermont.
“Hemp farmers in North Carolina and Vermont have been really receptive to working with the Tru-Hemp ID kit,” stated Digipath CSO Cindy Orser, Ph.D. “Farmers want to have the capability to definitively confirm what they are purchasing, especially when getting hemp seeds from other states or nations, or cannabis clones. It is rewarding to see our 1st genetic solution getting into a profitable beta test phase. We are enthusiastic about the industry chance and the interest from hemp farmers and hemp regulators.”
Dr. Orser has spent time with the Division of Agriculture employees in Vermont exactly where genetic testing to distinguish in between hemp and THC-wealthy strains of cannabis is currently offered for.
In July, Digipath announced the profitable in-residence testing of Tru-Hemp ID and revealed plans to beta-test the kit in Vermont, New York, North Carolina Oregon, Colorado, and California.